Aim: The risk factors for depressive symptoms in patients with Parkinson's disease (PD) under dopaminergic drug treatment are unclear. In this study, we examined whether some temperament traits are related to the presence of comorbid depression in PD patients, independent of the characteristics of illness and drug treatment. Methods: The participants in this study were 74 patients with idiopathic PD who were already treated with stable doses of levodopa or dopamine agonists. Depressive (n = 20) and non-depressive (n = 52) PD patients were assessed by means of the Unified Parkinson's Disease Rating Scale, Beck Depression Inventory, and Temperament Evaluation of Memphis, Pisa, Paris and San Diego Auto-questionnaire. The doses of levodopa and dopamine agonists were converted into levodopa equivalent daily dose. Results: The duration of treatment in the depressive group was significantly longer than in the non-depressive group (P = 0.03). The depressive patients had significantly higher scores on the Unified Parkinson's Disease Rating Scale than the non-depressive patients. Depressive (P < 0.0001), cyclothymic (P < 0.0001), anxious (P < 0.0001), and irritable (P = 0.02) temperament scores were significantly higher in depressive than in non-depressive patients. Hyperthymia scores were significantly higher in non-depressive patients than in depressive patients (P = 0.01). Logistic regression analysis revealed that depressive temperament traits (P = 0.03) significantly predicted the diagnosis of depression. In contrast, hyperthymic temperament seemed to be associated with the absence of depression (P = 0.006). Conclusion: Our results indicated that the severity of PD and duration of dopaminergic treatment were not predictive of the development of depression in PD patients. Depressive temperament strongly predicted the development of depression in our sample. Hyperthymic temperament seemed to be associated with patients without depression. We suggest that depressive temperament traits seem to be related to depression, while hyperthymic temperament may have a protective role in the risk of depression in PD patients.
INRODUCTION
Parkinson's disease (PD) is a chronic, neurodegenerative movement disorder that affects 1-2% of individuals older than 60 years of age.
1,2 Dopamine deficiency in the substantia nigra pars compacta and the presence of Lewy bodies and Lewy neurites are the predominant neurochemical abnormalities. 3 The main goal of treatment is to maintain independent function, to increase 'on' time, to decrease 'off' time, and to alleviate medication-related complications, such as dyskinesias, motor fluctuations, and some psychiatric problems. Levodopa (L-DOPA) remains the most effective treatment agent for symptomatic PD patients. 4, 5 Bromocriptine, pergolide, pramipexole, and ropinirole directly stimulate dopamine receptors.
Entacapone and tolcapone are catechol-Omethyltransferase inhibitors that decrease the degradation of L-DOPA and extend its half-life. Monoamine oxidase B inhibitors increase dopamine levels in the basal ganglia, inhibiting dopamine catabolism. 6, 7 Depressive symptoms are common in patients with PD and may complicate the course of the illness. The prevalence of depression in PD is estimated to be between 2.7% and 90%, with variations due inconsistent study methods and diagnoses. [8] [9] [10] [11] [12] Depressive symptoms may be reactive to part of a disabling chronic disease or endogenous as a result of a distinct major depressive episode. 13, 14 Depression in patients with PD has been reported to be associated with activities of daily living, 15 cognitive function, 16 and motor symptoms. 17 Patients with akinetic-rigid-type PD have a higher incidence of depression than classic PD patients with tremor, rigidity, and/or bradykinesia. 16, 18 Some risk factors associated with depression include right-sided motor symptoms and a longer duration of illnes. 16, 19 As PD progresses, the severity of depression may change, and depression can antedate the onset of motor symptoms. 20 Some previous studies found several personality traits, such as introversion, compulsive, cautiousness, and low sensation seeking, in PD patients. 21, 22 The individuals who later developed PD had fewer novelty-seeking features before the onset of the disease than healthy controls did. 21, 23, 24 In addition, significantly more harm avoidance traits were reported in PD patients compared to healthy controls. [24] [25] [26] [27] Long-term treatment with dopaminergic drugs may cause some neuropsychiatric complications such as delirium, agitation, restlessness, mood disorders, and cognitive dysfunctions. 4, 5 Moreover, there is not much evidence to prove that dopaminergic agonists improve mood in PD. 18 At present, the relationship between depression and dopaminergic drug treatment in PD patients is not well understood. Some studies reported that L-DOPA does not have antidepressant effects and causes depression in some patients. 28, 29 In contrast, some studies reported that L-DOPA may exert antidepressant properties by reducing akinetic (off ) states. 30 The antidepressant effects of pramipexole have been shown in various animal models and in both non-PD and PD patients. [31] [32] [33] [34] [35] Also, comparable with fluoxetine, pramipexole was found to be effective in patients with severe depressive symptoms. 36 Therefore, it is very reasonable to examine the association of premorbid temperament traits with the development of depression in PD patients who are under dopaminergic treatment. In the present study, we hypothesized that some temperament traits are related to the occurrence of comorbid depression in PD patients, independent of the characteristics of illness and drug treatment. 
METHODS Patients

RESULTS
Of the 74 patients, 20 patients (27.0%) met the Diagnostic and Statistical Manual of Mental Disorders, 4th edition, criteria for a current diagnosis of depression.
As indicated in Table 1 , the proportion of the women was significantly higher among the depressive patients than among the non-depressive patients (P = 0.049). There were no significant differences between the two groups with respect to age, marital status, duration of PD, previous history of any psychiatric disorder, and L-DOPA equivalent daily dose. The duration of treatment in the depressive group was significantly longer than in the non-depressive group (P = 0.034). The patients with depression had significantly higher scores on the UPDRS than those without depression. Depressive (P < 0.0001), cyclothymic (P < 0.0001), anxious (P < 0.0001), and irritable (P = 0.022) temperament scores were significantly higher in depressed patients than in non-depressed patients. In contrast, hyperthymia scores were found to be significantly higher in non-depressive patients than in those with depression (P = 0.012). Binary logistic regression was used to predict an outcome of depressive disorder among the 74 participants. The final model was able to explain between 52.8% and 76.4% of variance. The model was found to fit data adequately (Hosmer-Lemeshow χ 2 = 8.355, P = 0.400) and was able to predict 72.6% of all cases. Seven predictors were included in the model based on the enter method. Two of them significantly predicted depression status. The presence of depressive temperament traits (odds ratio = 1.562, 95% confidence interval: 1.032-2.363; P = 0.035) were significantly associated with the diagnosis of depression. In contrast, hyperthymic temperament seemed to predict the patients who did not have depression (odds ratio = 0.580, 95% confidence interval: 0.393-0.855; P = 0.006). Assumptions for linearity and multicollinearity were satisfied (Table 2) .
DISCUSSION
In the present study, our main objective was to investigate whether some temperament traits are related to the presence of comorbid depression in PD patients, independent of the illness severity and duration of dopaminergic treatment. The results showed that nearly one-third of our sample met the Diagnostic and Statistical Manual of Mental Disorders, 4th edition, criteria of depression. This is consistent with previous findings that reported a wide range of prevalence rates of depression (between 2.7% and 90%) in PD patients. 11, 12 This wide variation seems to be related to the sample characteristics, the heterogeneous diagnostic criteria, the different assessment techniques, and the statistical analyses used. 19 Some core symptoms of depression such as difficulty concentrating, loss of energy, psychomotor retardation, fatigue, and apathy may also be present in PD patients without depression. [51] [52] [53] Some previous studies found a positive association between depression and PD, but others reported no correlation. 18, 54, 55 The results of the current study are consistent with those indicating that the presence of depression was related to higher scores on the UPDRS and duration of treatment. [56] [57] [58] However, when these two variables were entered into logistic regression analysis together with temperament scores, higher scores on UPDRS, and a longer duration of treatment, the development of depression was not predicted in our patients. Therefore, this finding might suggest that the severity of PD and duration of treatment were not predictive of the development of depression in PD patients. Dopamine-mediated motor and mood variations related to the on/off phenomena suggest the role of dopamine in mood regulation. 59 Previous studies on antidepressive and depressogenic effects of dopaminergic drugs produced contradictory results. In our sample, the duration of treatment was significantly longer in depressive patients than in non-depressive ones. In addition, the L-DOPA equivalent daily dose did not differ between the depressive and nondepressive PD patients. None of the patients had taken an antidepressant for the last 3 months. Previous studies revealed that depressive, cyclothymic, hyperthymic and irritable temperaments were considered to be risk factors for affective disorders. [60] [61] [62] [63] [64] [65] Using the Temperament Evaluation of Memphis, Pisa, Paris and San Diego Auto-questionnaire, we found that cyclothymic, depressive, irritable, and anxious temperament traits were significantly higher in patients with depression than in those without depression. In contrast, hyperthymic temperament was more likely to be higher in the non-depressive group than in the depressive group. Logistic regression analysis revealed that only depressive temperament strongly predicted the development of depression in our sample. Hyperthymic temperament seemed to be associated with patients without depression. Taken as a whole, we report that although depressive PD patients had a more severe illness and longer treatment period, only depressive temperament best predicted the diagnosis of depression. We supposed that depressive temperament predisposed PD patients to adverse effects of the illness, as previously suggested. 60 ,66 Nevertheless, we should also consider that some depressive symptoms may negatively influence the depressive temperament scores as a limitation of this study. The finding of reduced novelty-seeking suggests the presence of a low externalizing/potentially impulsive personality trait in PD patients. 67 Previous studies also reported high scores of harm avoidance in patients with both depression and medicated PD. 21, 68 In addition, harm avoidance scores were found to positively correlate with depression severity in patients with PD. 21, 27 Recent studies pointed to an association among hyperthymic temperament, increased novelty-seeking, and lower harm avoidance scores. [69] [70] [71] [72] Temperamental predispositions in subjects who develop mood disorders seem to be related to specific disorders. Our findings indicate that depressive temperament traits may be related to depression, whereas hyperthymic temperament may have a protective role in decreasing the risk of depression in PD patients, as previously reported for some mental disorders.
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The major limitations of this study are the small sample size and the lack of a drug-naive patient group. Patients with PD not receiving treatment and those seeking treatment may have different profiles. Because of overlapping clinical symptoms of PD and depression, we might have failed to correctly measure the severity of depression. We did not study the psychological factors and disability that might be associated with developing depression in PD. We suggest that the personality traits associated with depression should be compared between patients with and without PD.
